Nu-Med Plus (NUMD) Assets Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -53.67% |
| Sep 30, 2025 | 16.80% |
| Jun 30, 2025 | -1.11% |
| Mar 31, 2025 | -13.26% |
| Dec 31, 2024 | -24.94% |
| Sep 30, 2024 | -48.89% |
| Jun 30, 2024 | -50.15% |
| Mar 31, 2024 | -68.37% |
| Dec 31, 2023 | -71.09% |
| Sep 30, 2023 | -72.34% |
| Jun 30, 2023 | -65.00% |
| Mar 31, 2023 | 7.75% |
| Dec 31, 2022 | 20.22% |
| Sep 30, 2022 | -66.42% |
| Jun 30, 2022 | -45.72% |
| Mar 31, 2022 | -62.84% |
| Dec 31, 2021 | -62.58% |
| Sep 30, 2021 | -54.74% |
| Jun 30, 2021 | -35.79% |
| Mar 31, 2021 | -4.28% |
| Dec 31, 2020 | 11.06% |
| Sep 30, 2020 | 12.24% |
| Jun 30, 2020 | 39.02% |
| Mar 31, 2020 | -48.70% |
| Dec 31, 2019 | 8.81% |
| Sep 30, 2019 | -30.84% |
| Jun 30, 2019 | -61.78% |
| Mar 31, 2019 | 6.70% |
| Dec 31, 2018 | 77.26% |
| Sep 30, 2018 | 106.52% |
| Jun 30, 2018 | 54.77% |
| Mar 31, 2018 | 47.82% |
| Dec 31, 2017 | 24.05% |
| Sep 30, 2017 | 29.19% |
| Jun 30, 2017 | -16.43% |
| Mar 31, 2017 | -11.32% |
| Dec 31, 2016 | -28.21% |
| Sep 30, 2016 | 55.98% |
| Jun 30, 2016 | 138.36% |
| Mar 31, 2016 | 21.94% |
| Dec 31, 2015 | -11.72% |
| Dec 31, 2014 | 433.14% |